Therapy News and Research

RSS

New discovery could expand the possibilities for medical use of Botox

PSI researchers have discovered a surprising trick that could expand the possibilities for medical use of botulinun toxin A1, better known under the name Botox, as an active agent.

18 Dec 2023

Psilocybin may benefit individuals with cancer and major depression

Results from a phase II clinical trial indicate that psilocybin, a hallucinogenic chemical found in certain mushrooms of the genus Psiloybe, may benefit individuals with cancer and major depression.

18 Dec 2023

Only 1 in 18 people with opioid use disorder get effective treatment after overdose

In the week following any hospital visit for an overdose, only 1 in 18 people with opioid use disorder begin a treatment known to be highly effective in reducing illness and deaths, according to new research in CMAJ (Canadian Medical Association Journal).

18 Dec 2023

Antibody treatment shields transplant patients against COVID-19

New research from Cedars-Sinai's Comprehensive Transplant Center found that a monoclonal antibody treatment reduced the risk of COVID-19 in a large group of solid organ transplant patients who were administered the drug as a preventive measure against the disease.

18 Dec 2023

Study supports limiting red meat intake for type 2 diabetes prevention, highlights alternative protein sources

Study finds that consumption of red, processed, and unprocessed meat significantly increases the risk of type 2 diabetes, suggesting the benefits of substituting meat with nuts, legumes, and dairy.

17 Dec 2023

Global study emphasizes early detection of familial hypercholesterolaemia in youth

Study on familial hypercholesterolaemia in children and adolescents from 48 countries highlights the need for early detection and management to prevent cardiovascular diseases.

17 Dec 2023

Experimental drug paired with a standard-care medication offers hope for kidney disease patients

In a clinical trial of patients with chronic kidney disease, an experimental drug significantly reduced albuminuria - albumin in urine, a sign of kidney damage - for 50% of participants.

15 Dec 2023

Unlocking radiation resistance: Missing protein key to suppressing cancer-fighting cells

A new study finds that radiation therapy (RT) suppresses a key protein called bone morphogenetic protein and activin membrane-bound inhibitor (BAMBI) and activates immune suppressive cells.

15 Dec 2023

New LMU-led DFG Research Unit eyes innovative gene therapies for retinal diseases

A new LMU-led DFG Research Unit is developing innovative approaches for treating retinal diseases.

15 Dec 2023

QUT scientists discover promising treatment for fatal endometrial cancer

QUT scientists have discovered a promising new therapy for a deadly type of endometrial cancer that has a poor prognosis if the cancer spreads or returns after initial treatment, a plight that affects 15-20 per cent of endometrial cancer patients.

15 Dec 2023

Blueprint Medicines announces approval of AYVAKYT for treatment of ISM patients in Europe

Blueprint Medicines Corporation today announced the European Commission has approved AYVAKYT® (avapritinib) for the treatment of adult patients with indolent systemic mastocytosis (ISM) with moderate to severe symptoms inadequately controlled on symptomatic treatment. AYVAKYT is the first and only approved therapy for people living with ISM in Europe.

15 Dec 2023

UCL researchers develop new gene therapy to cure severe childhood epilepsy

UCL researchers have developed a new gene therapy to cure a devastating form of childhood epilepsy, which a new study shows can significantly reduce seizures in mice.

14 Dec 2023

NIAID study identifies critical T-cell function missing in prior HIV vaccine candidates

An effective HIV vaccine may need to prompt strong responses from immune cells called CD8+ T cells to protect people from acquiring HIV, according to a new study from researchers at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and colleagues.

14 Dec 2023

Internationally renowned breast medical oncologist joins the David Geffen School of Medicine at UCLA

Dr. Aditya Bardia, a renowned breast medical oncologist and physician scientist who specializes in developing novel targeted and personalized therapies, has joined the David Geffen School of Medicine at UCLA and the UCLA Health Jonsson Comprehensive Cancer Center where he will assume several leadership roles across the institution.

14 Dec 2023

Therapy News and Research

New discovery could expand the possibilities for medical use of Botox

Psilocybin may benefit individuals with cancer and major depression

Only 1 in 18 people with opioid use disorder get effective treatment after overdose

Antibody treatment shields transplant patients against COVID-19

Study supports limiting red meat intake for type 2 diabetes prevention, highlights alternative protein sources

Global study emphasizes early detection of familial hypercholesterolaemia in youth

Experimental drug paired with a standard-care medication offers hope for kidney disease patients

Unlocking radiation resistance: Missing protein key to suppressing cancer-fighting cells

New LMU-led DFG Research Unit eyes innovative gene therapies for retinal diseases

QUT scientists discover promising treatment for fatal endometrial cancer

Blueprint Medicines announces approval of AYVAKYT for treatment of ISM patients in Europe

UCL researchers develop new gene therapy to cure severe childhood epilepsy

NIAID study identifies critical T-cell function missing in prior HIV vaccine candidates

Internationally renowned breast medical oncologist joins the David Geffen School of Medicine at UCLA

Uncovering barriers to heart failure medication access for low-income patients

New advance in the development of a test for early diagnosis of cancer

Atezolizumab plus carboplatin: A winning combination for metastatic triple-negative breast cancer

Researchers unveil new way to sensitize resistant tumors to treatment

Novel drug combinations could protect snakebite victims from devastating injuries

Researchers develop humanized mouse model for macrophage-targeted cancer immunotherapy

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News